The Board

Providing the knowledge and experience to help TauRx thrive

Abstract Image of Business People's Silhouettes in a Meeting
Prof Claude Wischik
Co-Founder, Chairman and Chief Executive

Professor Wischik is board-certified in psychiatry, professor of Old Age Psychiatry at the University of Aberdeen, Scotland. A pioneer in Tau research, he discovered the tau protein compositional structure of the Alzheimer’s tangles and established that it was possible to dissolve tangles with pharmaceutically viable compounds that act as Tau Aggregation Inhibitors


Hwang Hong Wei
Finance Director

Mr Hwang is a member of the Institute of Certified Public Accountants of Singapore and joined TauRx Pharmaceuticals Ltd in March 2010. Previously, he was Finance Director of LexisNexis Asia and held senior positions in finance in the IT and financial industry. He holds a Bachelor of Accountancy (Honours) from the National University of Singapore and a Master of Science in CFO Leadership from the Singapore Management University.


Tay Siew Choon
Deputy Chairman

Mr Tay has many years of experience in managing diverse technology businesses and was the COO of Singapore Technologies Pte Ltd. prior to his retirement in 2004. Holding a degree in electrical engineering and an MSc in systems engineering, he is also a board member at WisTa Laboratories Ltd. (a TauRx group company), Pan United Corporation Ltd. and Straco Corporation Ltd.


Dr Seng Shay Way
Managing Director

Dr Seng is a practising obstetrician, gynaecologist and reproductive specialist at Gleneagles Hospital, Singapore. He received his medical degree from the Royal College of Surgeons in Ireland and obtained his Masters in reproductive medicine from the University of New South Wales in Australia. He is currently the Medical director of Seng’s OG Practice Pte Ltd, a visiting IVF specialist at Raffles Hospital and board member of Age D’Or Healthcare Pte Ltd.


Dr Sushilan Vasoo
Director

Dr Vasoo is an Associate Professorial Fellow in the Department of Social Work, National University of Singapore and an independent director of AEI Corporation. His research areas cover social issues in ageing. He is also a board member of WisTa Laboratories Ltd and PoreDeen Pte Ltd. (TauRx group companies) and was a Member of Parliament in the Government of Singapore from 1984 to 2001 and Chairman of the Government Parliamentary Committee for Community Development.


George Chia
Director

Mr Chia has been running his own paper business for 42 years. He is also a board member of WisTa Laboratories Ltd. and PoreDeen Pte. Ltd. (TauRx Group companies), and the Chairman of Premier Disposable Products Ltd (Hong Kong) and Guangdong Josco Disposable Product Ltd (China). Prior to his present appointment, he was Managing Director of Kookaburra Paper Products Pte. Ltd and Premier Paper Doyleys Pte. Ltd.


Paul Cheng
Director

Mr. Cheng is Managing Director and Head of Corporate Planning at DBS Bank where he is responsible for driving the bank’s merger and acquisition activities and strategic initiatives. Between 2012-14, he was also concurrently the Chief Operating Officer for DBS Group Finance. Prior to joining DBS, Paul worked with the Monetary Authority of Singapore, Temasek Holdings and the Government of Singapore Investment Corporation. Paul graduated from Nanyang Technological University, Singapore and has been a Certified Public Accountant since 2000.


Tan Sri Lim Kok Thay
Director

Tan Sri Lim Kok Thay is the Chairman and Chief Executive of Genting Berhad, the ultimate holding company of the Genting Group, and has served in various positions within the Genting Group since 1976. He holds a Bachelor of Science in Civil Engineering from the University of London, UK, and attended the Programme for Management Development of Harvard Business School, Harvard University, USA. He is also a Visiting Professor in the Department of Electrical and Electronic Engineering, Imperial College, London, UK and an Honorary Professor of Xiamen University, China.


Tan Kong Han
Director

Mr Tan is the President and Chief Operating Officer and Executive Director of Genting Berhad as well as Chief Executive and Executive Director of Genting Plantations Berhad. He read economics and laws and has been conferred a Master of Arts by University of Cambridge. He was called to the English Bar (Lincoln’s Inn) in 1989 and the Malaysian Bar in 1990. He worked in investment banking prior to joining Tanjong Public Limited Company (“Tanjong”) as the Group Chief Operating Officer in 2003 and left Tanjong in 2007 to join Genting.


Tang Jialei
Director

Ms Tang is the managing director of Haiyi Holdings Pte Ltd, Director of Real Estate and Investments at Acrophyte, Inc, and a Board member at Cromwell Property Group. She is also founder of the art and design practice, a_void. Her work comprises architecture, finance, communication design,hospitality, philanthropy, and real estate. She holds a Master in Urban Planning from the Harvard Graduate School of Design, Bachelor of Fine Arts in Architectural Design and a Bachelor of Arts in Liberal Arts (Epistemology and Language) from The New School.


Goh Chung Meng
(Alternate Director to Tay Siew Choon) - Corporate Fundraising Team

Mr Goh is currently a Director of AVI-TECH Electronics Ltd. Prior to his present appointment, Mr Goh held senior positions in Deloitte & Touche Management Consultants, Carr Indosuez Asia (Merchant Banking unit of Credit Agricole) and Suez Asia Holdings (an Asian private equity fund). From 2001 to 2008, Mr Goh served as a Panel Member of a Singapore government innovation and research fund, The Enterprise Challenge Unit (TEC), PS 21 Office, Public Service Division, Prime Minister’s Office. Mr Goh graduated from the NUS Business School, National University of Singapore with a Bachelor of Business Administration (BBA).


Dr Loh Yin Sze
(Alternate Director to Dr Seng Shay Way) - Corporate Fundraising Team

Dr Loh graduated from the National University of Singapore with a Bachelor of Medicine and Bachelor of Surgery and did her clinical rotations in Singapore. She also trained in molecular biology basic research. In 2004, Dr Loh was awarded the NUS-NUH Annual Meeting “Young Doctor Award” for her research work in the field of discovery of novel therapeutics. Dr Loh has also worked as a Financial Research Analyst covering the healthcare, biomedical and pharmaceutical sectors when she was employed at Philip Securities Pte Ltd.


Mr Lin Daqi
(Alternate Director)

Mr Daqi is an Investment Manager with Haiyi Holdings Pte Ltd. He is responsible for the origination, evaluation, structuring and execution of investments across industries and geographies. He started his career in the financial industry in 2009 and had served in various capacities within the Strategic Advisory and Mergers & Acquisitions team within DBS. His key directorships include ARA US Hospitality Trust, NonIndependent Non-Executive Director (Since Jan 2020) and WhiteCoat Global, Director (Since Mar 2021)


Lawrence Wong Kin Meng
General Counsel and Company Secretary

Mr. Wong was called to the English Bar in 1983 as a Barrister and admitted to the Singapore Bar as an Advocate & Solicitor in 1984. He worked in several large and medium-sized law firms in Singapore, before establishing his own law firm in July 2000. Concurrently with his law practice, he holds appointments as a Notary Public and Commissioner for Oaths.